Acceptability of a Novel Levofloxacin Dispersible Tablet Formulation in Young Children Exposed to Multidrug-resistant Tuberculosis. (2019)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1097/inf.0000000000002268
PubMed Identifier: 30550511
Publication URI: http://europepmc.org/abstract/MED/30550511
Type: Journal Article/Review
Volume: 38
Parent Publication: The Pediatric infectious disease journal
Issue: 6
ISSN: 0891-3668